Skip to Main Content

About Terumo Cardiovascular Group

Member of a cardiac surgery team

We’re part of your team.

At Terumo Cardiovascular Group, we develop, manufacture and distribute medical devices for cardiac and vascular surgery with an emphasis on cardiopulmonary bypass, intra-operative monitoring and vascular grafting. This includes a full-line of perfusion products, endoscopic vessel harvesting products and surgical stabilization products. In addition, Terumo CV Group is the exclusive distributor of Vascutek® Vascular Grafts in the U.S.

Our mission is to work as a team to save one more life, today and every day. We do this by providing lifesaving technology to cardiac surgery teams around the world.

Our parent company, Terumo Corporation, is a global medical device manufacturer focused on cardiac and vascular specialties, hospital products, and home health care. Established in 1921, Terumo Corporation has more than 20,000 associates in 82 sales offices and 24 production facilities. It provides medical devices and services for the benefit of patients and medical settings in more than 160 countries.

Terumo CV Group — and all Terumo companies — embody Terumo Corporation's commitment to bring revolutionary advances to the frontlines of healthcare. Our global associates constantly seek innovation and take on new challenges to positively impact healthcare around the world.

Learn more about Terumo Corporation’s Global Network external link icon

Our History

In 1999, Terumo Corporation merged three of the most established and trusted brands in perfusion products — CAPIOX®, Sarns™ and CDI® — to create Terumo Cardiovascular Systems. The company inherited a rich history that stretches back to the pioneering years of open-heart surgery.

Since 1999, Terumo Cardiovascular Group has expanded its cardiac surgery product line to include vascular grafts, endoscopic vessel harvesting, and more.

Terumo Corporation, Terumo CV Group’s parent company, spans an even greater time period in medical device development. Its first product, a clinical thermometer, was developed in the early 1920s. It has continued to grow and is now one of the largest medical device manufacturers in the world. Visit Terumo Corporation's website to view their full history.

Today, in virtually every cardiac surgery center around the world, heart teams choose products made by Terumo CV Group.

Timeline of Innovation

1921-2000

1921

The Sekisen Ken-onki is founded, eventually becoming Terumo Corporation

1922

Terumo Corporation introduced its first product — a clinical thermometer

1961

Dick Sarns delivers his first custom-made heart-lung machine

1963

Sarns, Inc. produced the S2000, its first modular heart-lung machine

1971

Terumo America Inc. and Terumo Europe S.A. were founded

1982

CAPIOX® II Oxygenator, the world's first hollow fiber oxygenator, introduced

1984

Cardiovascular Devices Inc. (CDI) introduced the Gas Stat System, the industry's first continuous monitor

1988

CAPIOX® E Oxygenator launched, offering venous gravity drainage and an arterial reservoir for ease-of-use

1992

Sarns, Inc. introduced the Sarns™ Modular Perfusion System 8000

1993

CAPIOX® SX Oxygenator launched

1998

CDI® Blood Parameter Monitoring System 500 introduced

1999

Terumo Corporation acquired the Sarns™ and CDI® brands from 3M and merged the technologies with CAPIOX® to form Terumo Cardiovascular Systems

Xcoating™, a non-heparin biocompatible coating, launched

2001-2010

2000

CAPIOX RX Oxygenator introduced

2001

Terumo Cardiovascular Systems entered into an exclusive distribution agreement with Pall Corporation for cardiovascular filters

2002

CAPIOX Baby RX™ (RX05) Neonatal Oxygenator launched

Terumo Corporation acquired Vascutek Ltd., a global leader in artificial vascular grafts

2003

Terumo® Advanced Perfusion System 1 introduced

2005

Terumo Corporation became number one in the global perfusion products market and began to expand its portfolio to new product categories in the cardiac operating room

VirtuoSaph™ Endoscopic Vein Harvesting System launched

2006

Terumo Cardiovascular Systems entered into an exclusive distribution agreement with Harvest Technologies Corporation to distribute SmartPrep® platelet gel therapy in the North American cardiovascular market

TLink™ Data Management System introduced

CAPIOX® RX15/25 Oxygenators launched in the United States, extending its offering of hollow-fiber oxygenators for use with all patients

2007

Terumo Cardiovascular Systems became the exclusive distributor of Vascutek® Vascular Grafts in the United States

2008

CAPIOX® FX Oxygenator, the industry's first oxygenator with an integrated arterial filter, introduced

CAPIOX® FX05 Oxygenator, the industry's first pediatric oxygenator with an integrated arterial filter, launched

2011-Present

2011

Terumo Corporation acquired Harvest Technologies Corporation, a leader in the development of point-of-care cell therapy

2012

Terumo Cardiovascular Group acquired the Orpheus™ Perfusion Simulation technology from Ulco Technologies

2013

Terumo Cardiovascular Group formed, creating a global headquarters focused on the needs of cardiac surgery teams worldwide Terumo Cardiovascular Group acquired the beating heart and stabilization technologies from Estech Cardiothoracic Stabilization Technologies

2014

Terumo Cardiovascular Group became the exclusive distributor of Nonin Medical's SenSmart™ Model X-100 in the United States